Skip to content

A Comparative Study of Postoperative Analgesic Efficacy Between Butorphanol and Tegileridine in Gynecological Laparoscopic Surgery: A Randomized Controlled Trial

A Comparative Study of Postoperative Analgesic Efficacy Between Butorphanol and Tegileridine in Gynecological Laparoscopic Surgery: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600130737
Enrollment
Unknown
Registered
2026-08-24
Start date
2026-08-24
Completion date
Unknown
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological Laparoscopic Surgery

Interventions

Tegileridine Group:Tegileridine Group
Butorphanol Group:Butorphanol Group

Sponsors

Hainan Medical College First Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients whose diagnosis met the indications for gynecological laparoscopic surgery as defined in Obstetrics and Gynecology. 2.ASA physical status I or II. 3.Patients with good treatment compliance and no history of psychiatric disorders.

Exclusion criteria

Exclusion criteria: 1.Hyperthyroidism; 2.Patients with dysfunction of vital organs, including the heart, brain, liver, and kidneys. 3.Patients with comorbid psychiatric and neurological disorders. 4.Patients with severe cardiovascular and cerebrovascular diseases. 5.Patients with comorbid infectious diseases. 6.Patients with language or hearing impairments that precluded adequate cooperation with the treatment protocol. 7.Patients who were pregnant or lactating. 8.Patients with alcohol or substance abuse.

Design outcomes

Primary

MeasureTime frame
Postoperative pain scores were recorded using the Visual Analogue Scale (VAS) and compared among the three groups.;

Countries

China

Contacts

Public ContactXie Hai

Hainan Medical College First Affiliated Hospital

hnxh2003@163.com+86 898 66773791

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026